On March 6, 2022, Josh Richardson resigned from the Board of Directors (the Board) of Sierra Oncology, Inc. (the Company) and from all committees of the Board for personal reasons. The resignation of Dr. Richardson is effective immediately and is not the result of any disagreement with the Company relating to the Company's operations, policies or practices.
Sierra Oncology, Inc.
Equities
SRRA
US82640U4040
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.87B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |